Creative Biolabs gathers published antibody usage data from journals, partners, patents to generate a large, customized proprietary data set, based on which, we create an algorithm capable of computationally generating, screening, and optimizing hundreds of millions of therapeutic antibodies. Our monthly-updated machine learning algorithm is able to rapidly screen for therapeutic antibodies with a high probability of success.